Ursprung des Netzwerks ersten Grades von David Plante
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Plante
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Director of Finance/CFO | |
| ARQULE, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ACUSPHERE, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LEMAITRE VASCULAR, INC. | Medical Specialties | Comptroller/Controller/Auditor | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| George Washington University | College/University | Undergraduate Degree | |
WorldStreet Corp.
 WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky. | Packaged Software | Director of Finance/CFO | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMRYT PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Harvard Medical School | College/University | Graduate Degree | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Rochester Simon Business School | College/University | Masters Business Admin | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Biotechnology | Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bentley University | College/University | Undergraduate Degree | |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | Biotechnology | Chief Executive Officer | |
| University of New Hampshire | College/University | Undergraduate Degree | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Corporate Officer/Principal | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | General Counsel | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO | |
| Middlebury College | College/University | Undergraduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree | |
| Northeastern University School of Law | College/University | Graduate Degree | |
| ENGENE HOLDINGS INC. | Biotechnology | General Counsel | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | General Counsel | |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Goodwin Procter LLP is a law firm which provides advice to companies in public and private enterprises. It provides services to financial, life sciences, private equity, real estate, and technolgy industries. The company was founded in 1912 and is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 35 |
| Israel | 6 |
| Vereinigtes Königreich | 3 |
| Kanada | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 4 |
| Consumer Non-Durables | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 54 |
| Corporate Officer/Principal | 36 |
| Chief Executive Officer | 22 |
| Chief Tech/Sci/R&D Officer | 21 |
| President | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| David Stack | 27 |
| Scott Minick | 23 |
| Gary Patou | 17 |
| John Scarlett | 13 |
| William Ludlam | 13 |
| Mark J. Fitzpatrick | 12 |
| John Thero | 11 |
| Rajkumar Kannan | 11 |
| Anand Varadan | 9 |
| Roni Mamluk | 9 |
| lee Giguere | 8 |
| David H. Schubert | 7 |
| John Doyle | 7 |
| Asi Haviv | 4 |
| Drew Enamait | 4 |
- Börse
- Insiders
- David Plante
- Unternehmensverbindungen
